- Home
- JBLU vs WGS Comparison
JBLU vs WGS Comparison
Compare JBLU & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- WGS
- Stock Information
- Founded
- JBLU 1998
- WGS 2017
- Country
- JBLU United States
- WGS United States
- Employees
- JBLU N/A
- WGS N/A
- Industry
- JBLU Air Freight/Delivery Services
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- JBLU Consumer Discretionary
- WGS Technology
- Exchange
- JBLU Nasdaq
- WGS Nasdaq
- Market Cap
- JBLU 2.1B
- WGS 2.0B
- IPO Year
- JBLU N/A
- WGS N/A
- Fundamental
- Price
- JBLU $6.10
- WGS $75.67
- Analyst Decision
- JBLU Sell
- WGS Strong Buy
- Analyst Count
- JBLU 13
- WGS 5
- Target Price
- JBLU $6.55
- WGS $80.60
- AVG Volume (30 Days)
- JBLU 22.9M
- WGS 850.6K
- Earning Date
- JBLU 01-28-2025
- WGS 02-18-2025
- Dividend Yield
- JBLU N/A
- WGS N/A
- EPS Growth
- JBLU N/A
- WGS N/A
- EPS
- JBLU N/A
- WGS N/A
- Revenue
- JBLU $9,279,000,000.00
- WGS $267,228,000.00
- Revenue This Year
- JBLU N/A
- WGS $43.70
- Revenue Next Year
- JBLU $5.07
- WGS $17.28
- P/E Ratio
- JBLU N/A
- WGS N/A
- Revenue Growth
- JBLU N/A
- WGS 29.41
- 52 Week Low
- JBLU $4.50
- WGS $3.62
- 52 Week High
- JBLU $8.31
- WGS $98.87
- Technical
- Relative Strength Index (RSI)
- JBLU 31.99
- WGS 47.76
- Support Level
- JBLU $7.66
- WGS $73.50
- Resistance Level
- JBLU $8.21
- WGS $81.50
- Average True Range (ATR)
- JBLU 0.45
- WGS 7.11
- MACD
- JBLU -0.20
- WGS -0.45
- Stochastic Oscillator
- JBLU 14.01
- WGS 29.03
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.